Use of long-acting beta2 agonists in arginine-16 homozygous patients with asthma.
Green
R H
RH
Pavord
I D
ID
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000235:genetics; D019819:Budesonide / Q000008:administration & dosage; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage; D000068759:Formoterol Fumarate; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D018343:Receptors, Adrenergic, beta-2; D019819:Budesonide; D000420:Albuterol; D000068759:Formoterol Fumarate